Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir

Pediatr Int. 2003 Aug;45(4):458-60. doi: 10.1046/j.1442-200x.2003.01746.x.

Abstract

Objective: The purpose of the present study was to determine the degree of spread of varicella-zoster virus to the environment (VZV) from varicella patients who received oral acyclovir treatment.

Methods: Over a period of 8 months, seven healthy children (two girls and five boys, 23-64 months of age) with varicella who visited Fujita Health University School of Medicine were treated with routine doses of oral acyclovir (ACV) for 5 days, commencing within 24 h after onset of the disease. Swab samples from the throats of patients and their family members as well as from air purifier filters in their houses were collected for 7 days as frequently as possible after starting treatment for the disease. The VZV DNA in the samples was identified by a sensitive polymerase chain reaction amplification assay.

Results: The VZV DNA was detected in 33-100% of throat swab samples from varicella patients by day 7 of the disease, in 17-32% of throat swab samples from family members by day 4 and in 29% of filters from air purifiers by day 3.

Conclusions: The results suggest a broad spread of VZV, probably by the airborne route, from the patients with varicella even after the administration of oral ACV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / therapeutic use
  • Air Microbiology
  • Antiviral Agents / therapeutic use
  • Chickenpox / drug therapy
  • Chickenpox / virology*
  • DNA, Viral / analysis*
  • Family Health
  • Female
  • Herpesvirus 3, Human / genetics*
  • Humans
  • Infant
  • Male
  • Pharynx / virology

Substances

  • Antiviral Agents
  • DNA, Viral
  • Acyclovir